Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03175068 · ClinicalTrials.gov registry record · NA
Transdiagnostic Brain-Behavior Profiling to Enhance Cognitive Behavioral Therapy Response
A NA study, sponsored by University of Illinois at Chicago.
- Completed
- Registry status
- NA
- Development phase
- 203
- Enrollment target
NCT03175068 is a NA study that has completed, run by University of Illinois at Chicago. The registered enrollment target is 203 participants.
The verdict
NCT03175068, a NA study, has completed, sponsored by University of Illinois at Chicago.
- COMPLETED
- Registry status
- NA
- Development phase
- 203 participants
- Enrollment target
Study Summary
Many patients with Major Depressive Disorder (MDD) and generalized Social Anxiety Disorder (gSAD) are treated with cognitive behavioral therapy (CBT) but few have meaningful improvement. MDD and gSAD are diseases of brain dysfunction that manifest as impaired emotion regulation; CBT teaches emotion regulation strategies but how it works in the brain remains largely unknown. Individual differences in brain function related to emotion regulation may make some patients better suited for CBT and CBT may remedy the brain dysfunction that underlies these disorders. This project will compare CBT with a placebo psychotherapy (i.e., supportive therapy) in MDD and gSAD to test, validate, and refine brain-based markers and examine mechanisms of change to examine how CBT works and for whom.
Interventions
- BEHAVIORAL CBT
- BEHAVIORAL ST
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 203 participants |
| Start Date | 2017-07-05 |
| Est. Completion | 2022-03-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03175068
The ClinicalTrials.gov registry entry for NCT03175068 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 203 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Illinois at Chicago, which has 430 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which CBT is the first listed.
NCT03175068 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03175068 about?
NCT03175068 is a clinical study titled "Transdiagnostic Brain-Behavior Profiling to Enhance Cognitive Behavioral Therapy Response". Many patients with Major Depressive Disorder (MDD) and generalized Social Anxiety Disorder (gSAD) are treated with cognitive behavioral therapy (CBT) but few have meaningful improvement. MDD and gSAD are diseases of brain dysfunction that manifest as impaired emotion regulation; CBT teaches emotion ...
What is the current status of trial NCT03175068?
This trial is currently completed. It is a NA study. The enrollment target is 203 participants. The study started on 2017-07-05. Estimated completion is 2022-03-01.
What interventions are being tested in trial NCT03175068?
The interventions under investigation include: CBT (BEHAVIORAL), ST (BEHAVIORAL).
Who is sponsoring clinical trial NCT03175068?
This trial is sponsored by University of Illinois at Chicago, which has 430 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.